{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:27:44Z","timestamp":1790065664196,"version":"4.0.1"},"reference-count":167,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Research Council","award":["617445"],"award-info":[{"award-number":["617445"]}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"crossref","award":["302303"],"award-info":[{"award-number":["302303"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Rimonim Consortium"},{"name":"MAGNET Program of the Office of the Chief Scientist of the Israel Ministry of Industry, Trade and Labor","award":["54206"],"award-info":[{"award-number":["54206"]}]},{"name":"Office of the Chief Scientist of the Ministry of Economics","award":["53516"],"award-info":[{"award-number":["53516"]}]},{"name":"Israel Cancer Association \u2013 ICA-USA","award":["20150909"],"award-info":[{"award-number":["20150909"]}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"crossref","award":["918\/14"],"award-info":[{"award-number":["918\/14"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007349","name":"Israeli National Nanotechnology Initiative","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007349","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Focal Technology Area"},{"name":"Leona M. and Harry B. Helmsley Nanotechnology Research"},{"DOI":"10.13039\/501100001738","name":"Ministry of Science, Technology and Space of Israel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001738","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Foreign Affairs of Italy","award":["0601165111"],"award-info":[{"award-number":["0601165111"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.biotechadv.2015.04.008","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T23:22:58Z","timestamp":1430004178000},"page":"1294-1309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"P3","title":["Achieving successful delivery of oligonucleotides \u2014 From physico-chemical characterization to in vivo evaluation"],"prefix":"10.1016","volume":"33","author":[{"given":"Anna","family":"Scomparin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Polyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adva","family":"Krivitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Satchi-Fainaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biotechadv.2015.04.008_bb0005","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1172\/JCI33494","article-title":"Nonviral delivery of synthetic siRNAs in vivo","volume":"117","author":"Akhtar","year":"2007","journal-title":"J Clin Invest"},{"issue":"32","key":"10.1016\/j.biotechadv.2015.04.008_bb0010","doi-asserted-by":"crossref","first-page":"12881","DOI":"10.1073\/pnas.1306529110","article-title":"Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery","volume":"110","author":"Alabi","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.biotechadv.2015.04.008_bb0015","doi-asserted-by":"crossref","first-page":"e52207","DOI":"10.1371\/journal.pone.0052207","article-title":"Influence of the internalization pathway on the efficacy of siRNA delivery by cationic fluorescent nanodiamonds in the Ewing sarcoma cell model","volume":"7","author":"Alhaddad","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/wnan.1157","article-title":"Recent advances in stealth coating of nanoparticle drug delivery systems","volume":"4","author":"Amoozgar","year":"2012","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"35","key":"10.1016\/j.biotechadv.2015.04.008_bb0025","doi-asserted-by":"crossref","first-page":"8949","DOI":"10.1016\/j.biomaterials.2013.07.060","article-title":"Brain-targeting delivery for RNAi neuroprotection against cerebral ischemia reperfusion injury","volume":"34","author":"An","year":"2013","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biotechadv.2015.04.008_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/15665232113136660005","article-title":"General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination","volume":"13","author":"Baldo","year":"2013","journal-title":"Curr Gene Ther"},{"issue":"4","key":"10.1016\/j.biotechadv.2015.04.008_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/oli.2008.0164","article-title":"Chemical modification of siRNAs for in vivo use","volume":"18","author":"Behlke","year":"2008","journal-title":"Oligonucleotides"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s13346-013-0160-0","article-title":"Overcoming obstacles in microRNA delivery towards improved cancer therapy","volume":"4","author":"Ben-Shushan","year":"2014","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0045","first-page":"103","article-title":"Polyelectrolyte complexes of DNA and polycations as gene delivery vectors","volume":"256","author":"Bertin","year":"2014"},{"issue":"9","key":"10.1016\/j.biotechadv.2015.04.008_bb0050","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1103\/PhysRevLett.56.930","article-title":"Atomic force microscope","volume":"56","author":"Binnig","year":"1986","journal-title":"Phys Rev Lett"},{"issue":"4","key":"10.1016\/j.biotechadv.2015.04.008_bb0055","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.biomaterials.2012.10.024","article-title":"Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery","volume":"34","author":"Biswas","year":"2013","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0060","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm1164","article-title":"Inhibition of respiratory viruses by nasally administered siRNA","volume":"11","author":"Bitko","year":"2005","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.biotechadv.2015.04.008_bb0065","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1073\/pnas.92.16.7297","article-title":"A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine","volume":"92","author":"Boussif","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.biotechadv.2015.04.008_bb0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.biotechadv.2015.04.008_bb0075","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.130119","article-title":"A systems biology analysis of the changes in gene expression via silencing of HPV-18 E1 expression in HeLa cells","volume":"4","author":"Castillo","year":"2014","journal-title":"Open Biol"},{"issue":"21","key":"10.1016\/j.biotechadv.2015.04.008_bb0080","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1016\/j.biomaterials.2011.03.042","article-title":"Co-delivery of small interfering RNA and plasmid DNA using a polymeric vector incorporating endosomolytic oligomeric sulfonamide","volume":"32","author":"Chang Kang","year":"2011","journal-title":"Biomaterials"},{"issue":"42","key":"10.1016\/j.biotechadv.2015.04.008_bb0090","doi-asserted-by":"crossref","first-page":"32807","DOI":"10.1074\/jbc.M004913200","article-title":"A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides","volume":"275","author":"Chen","year":"2000","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.biotechadv.2015.04.008_bb0085","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1517\/17425247.2014.926886","article-title":"RNA interference technology for anti-VEGF treatment","volume":"11","author":"Chen","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"10.1016\/j.biotechadv.2015.04.008_bb0095","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1021\/mp4006358","article-title":"Poly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epithelium","volume":"11","author":"Conti","year":"2014","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.biotechadv.2015.04.008_bb0100","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nnano.2014.84","article-title":"In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight","volume":"9","author":"Dahlman","year":"2014","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.addr.2014.09.010","article-title":"Combination of microRNA therapeutics with small-molecule anticancer drugs: mechanism of action and co-delivery nanocarriers","volume":"81","author":"Dai","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"10.1016\/j.biotechadv.2015.04.008_bb9995","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1158\/1535-7163.MCT-14-0209","article-title":"Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancer","volume":"13","author":"Daige","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"7291","key":"10.1016\/j.biotechadv.2015.04.008_bb0110","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1021\/mp700108r","article-title":"Biodegradable, cationic methacrylamide-based polymers for gene delivery to ovarian cancer cells in mice","volume":"5","author":"de Wolf","year":"2008","journal-title":"Mol Pharm"},{"issue":"8","key":"10.1016\/j.biotechadv.2015.04.008_bb0120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nmat898","article-title":"The use of environmental scanning electron microscopy for imaging wet and insulating materials","volume":"2","author":"Donald","year":"2003","journal-title":"Nat Mater"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1042\/cs1040027","article-title":"The inflammatory macrophage: a story of Jekyll and Hyde","volume":"104","author":"Duffield","year":"2003","journal-title":"Clin Sci (Lond)"},{"issue":"6836","key":"10.1016\/j.biotechadv.2015.04.008_bb0130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0135","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1006\/bbrc.1997.6125","article-title":"Gene transfer mediated by polyarginine requires a formation of big carrier-complex of DNA aggregate","volume":"231","author":"Emi","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.biotechadv.2015.04.008_bb0140","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/bjc.2014.215","article-title":"Oncogenic KRAS signalling in pancreatic cancer","volume":"111","author":"Eser","year":"2014","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.biotechadv.2015.04.008_bb0145","doi-asserted-by":"crossref","first-page":"e6121","DOI":"10.1371\/journal.pone.0006121","article-title":"Evidence for X-chromosomal schizophrenia associated with microRNA alterations","volume":"4","author":"Feng","year":"2009","journal-title":"PLoS One"},{"issue":"Suppl. 3","key":"10.1016\/j.biotechadv.2015.04.008_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000088479","article-title":"VEGF as a therapeutic target in cancer","volume":"69","author":"Ferrara","year":"2005","journal-title":"Oncology"},{"issue":"6669","key":"10.1016\/j.biotechadv.2015.04.008_bb0155","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"issue":"5\u20136","key":"10.1016\/j.biotechadv.2015.04.008_bb0165","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/elps.1150100515","article-title":"Measurement of protein\u2013DNA interaction parameters by electrophoresis mobility shift assay","volume":"10","author":"Fried","year":"1989","journal-title":"Electrophoresis"},{"issue":"23","key":"10.1016\/j.biotechadv.2015.04.008_bb0160","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1093\/nar\/9.23.6505","article-title":"Equilibria and kinetics of lac repressor\u2013operator interactions by polyacrylamide gel electrophoresis","volume":"9","author":"Fried","year":"1981","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.biotechadv.2015.04.008_bb0170","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1211\/jpp.61.08.0002","article-title":"Dendrimers as therapeutic agents: a systematic review","volume":"61","author":"Gajbhiye","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2014.09.001","article-title":"Nanocarrier mediated delivery of siRNA\/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances","volume":"194C","author":"Gandhi","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4137\/OED.S4878","article-title":"Bevasiranib for the treatment of wet, age-related macular degeneration","volume":"2","author":"Garba","year":"2010","journal-title":"Ophthalmol Eye Dis"},{"issue":"5","key":"10.1016\/j.biotechadv.2015.04.008_bb0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/occmed\/kql052","article-title":"Nanomedicines and nanotoxicology: some physiological principles","volume":"56","author":"Garnett","year":"2006","journal-title":"Occup Med (Lond)"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-3155-12-13","article-title":"Biscarbamate cross-linked low molecular weight polyethylenimine polycation as an efficient intra-cellular delivery cargo for cancer therapy","volume":"12","author":"Ge","year":"2014","journal-title":"J Nanobiotechnol"},{"issue":"5","key":"10.1016\/j.biotechadv.2015.04.008_bb0195","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0731-7085(00)00250-8","article-title":"Rapid and sensitive ethidium bromide fluorescence quenching assay of polyamine conjugate\u2013DNA interactions for the analysis of lipoplex formation in gene therapy","volume":"22","author":"Geall","year":"2000","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0200","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1038\/mtna.2012.43","article-title":"Gene silencing mediated by siRNA-binding fusion proteins is attenuated by double-stranded RNA-binding domain structure","volume":"1","author":"Geoghegan","year":"2012","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"10.1016\/j.biotechadv.2015.04.008_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/oli.2010.0235","article-title":"Efficient gene silencing in lungs and liver using imidazole-modified chitosan as a nanocarrier for small interfering RNA","volume":"20","author":"Ghosn","year":"2010","journal-title":"Oligonucleotides"},{"issue":"7","key":"10.1016\/j.biotechadv.2015.04.008_bb0210","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nbt.2612","article-title":"Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape","volume":"31","author":"Gilleron","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"27","key":"10.1016\/j.biotechadv.2015.04.008_bb0215","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.biotechadv.2015.04.008_bb0220","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/ar4003009","article-title":"Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics","volume":"47","author":"Gu","year":"2014","journal-title":"Acc Chem Res"},{"issue":"21","key":"10.1016\/j.biotechadv.2015.04.008_bb0225","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1016\/j.biomaterials.2013.03.060","article-title":"Effect of binding affinity for siRNA on the in vivo antitumor efficacy of polyplexes","volume":"34","author":"Han","year":"2013","journal-title":"Biomaterials"},{"issue":"6894","key":"10.1016\/j.biotechadv.2015.04.008_bb0230","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/418244a","article-title":"RNA interference","volume":"418","author":"Hannon","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/nl2035354","article-title":"Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer","volume":"12","author":"Hasan","year":"2012","journal-title":"Nano Lett"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0240","doi-asserted-by":"crossref","first-page":"262731","DOI":"10.1155\/2012\/262731","article-title":"Cyclodextrin-containing polymers: versatile platforms of drug delivery materials","volume":"2012","author":"Heidel","year":"2012","journal-title":"J Drug Deliv"},{"issue":"10","key":"10.1016\/j.biotechadv.2015.04.008_bb0245","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jps.20457","article-title":"Folate receptor-mediated drug targeting: from therapeutics to diagnostics","volume":"94","author":"Hilgenbrink","year":"2005","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.biotechadv.2015.04.008_bb0250","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/wnan.1228","article-title":"Polyethylenimines for siRNA and miRNA delivery in vivo","volume":"5","author":"Hobel","year":"2013","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0255","first-page":"265","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems \u2014 a review (part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop J Pharm Res"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0260","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/mt.2008.220","article-title":"Chitosan\/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model","volume":"17","author":"Howard","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1479-0556-9-15","article-title":"HCV entry receptors as potential targets for siRNA-based inhibition of HCV","volume":"9","author":"Jahan","year":"2011","journal-title":"Genet Vaccines Ther"},{"issue":"1\u20132","key":"10.1016\/j.biotechadv.2015.04.008_bb0270","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejps.2011.10.029","article-title":"Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes","volume":"45","author":"Jean","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0275","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2011.07.009","article-title":"HPMA\u2013oligolysine copolymers for gene delivery: optimization of peptide length and polymer molecular weight","volume":"155","author":"Johnson","year":"2011","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0280","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/hum.2007.179","article-title":"Overcoming the innate immune response to small interfering RNA","volume":"19","author":"Judge","year":"2008","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.biotechadv.2015.04.008_bb0285","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nbt1081","article-title":"Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA","volume":"23","author":"Judge","year":"2005","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0290","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.canlet.2011.02.014","article-title":"Therapeutic targeting of the mitotic spindle checkpoint through nanoparticle-mediated siRNA delivery inhibits tumor growth in vivo","volume":"304","author":"Kaestner","year":"2011","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.biotechadv.2015.04.008_bb0295","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/mt.2011.294","article-title":"Action and reaction: the biological response to siRNA and its delivery vehicles","volume":"20","author":"Kanasty","year":"2012","journal-title":"Mol Ther"},{"issue":"36","key":"10.1016\/j.biotechadv.2015.04.008_bb0300","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1016\/j.biomaterials.2013.08.036","article-title":"Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles","volume":"34","author":"Kanazawa","year":"2013","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.biotechadv.2015.04.008_bb0305","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/gt.2013.29","article-title":"Virus-mimetic polyplex particles for systemic and inflammation-specific targeted delivery of large genetic contents","volume":"20","author":"Kang","year":"2013","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.biotechadv.2015.04.008_bb0310","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/AAC.02768-13","article-title":"Targeted small interfering RNA-immunoliposomes as a promising therapeutic agent against highly pathogenic Avian Influenza A (H5N1) virus infection","volume":"58","author":"Khantasup","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"27","key":"10.1016\/j.biotechadv.2015.04.008_bb0335","doi-asserted-by":"crossref","first-page":"7970","DOI":"10.1016\/j.biomaterials.2014.05.070","article-title":"Targetable micelleplex hydrogel for long-term, effective, and systemic siRNA delivery","volume":"35","author":"Kim","year":"2014","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biotechadv.2015.04.008_bb0320","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/gt.2012.49","article-title":"Matrix metalloproteinase-inspired suicidal treatments of diabetic ulcers with siRNA-decorated nanofibrous meshes","volume":"20","author":"Kim","year":"2013","journal-title":"Gene Ther"},{"issue":"5","key":"10.1016\/j.biotechadv.2015.04.008_bb0330","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/mt.2010.27","article-title":"Targeted delivery of siRNA to macrophages for anti-inflammatory treatment","volume":"18","author":"Kim","year":"2010","journal-title":"Mol Ther"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0325","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2011.08.014","article-title":"Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA","volume":"427","author":"Kim","year":"2012","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0315","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2013.02.031","article-title":"Anti-apoptotic cardioprotective effects of SHP-1 gene silencing against ischemia\u2013reperfusion injury: use of deoxycholic acid-modified low molecular weight polyethyleneimine as a cardiac siRNA-carrier","volume":"168","author":"Kim","year":"2013","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0340","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.addr.2009.10.004","article-title":"HPMA copolymers: origins, early developments, present, and future","volume":"62","author":"Kopecek","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"1\u20132","key":"10.1016\/j.biotechadv.2015.04.008_bb0345","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpharm.2011.02.001","article-title":"Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems","volume":"417","author":"Kuntsche","year":"2011","journal-title":"Int J Pharm"},{"issue":"5\u20136","key":"10.1016\/j.biotechadv.2015.04.008_bb0350","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/CS20140005","article-title":"Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges","volume":"127","author":"Kwekkeboom","year":"2014","journal-title":"Clin Sci"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0355","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00705-008-0262-z","article-title":"Inhibition of influenza A virus replication by short double-stranded oligodeoxynucleotides","volume":"154","author":"Kwok","year":"2009","journal-title":"Arch Virol"},{"issue":"27","key":"10.1016\/j.biotechadv.2015.04.008_bb0360","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1038\/sj.onc.1207616","article-title":"Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis","volume":"23","author":"Lakka","year":"2004","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.biotechadv.2015.04.008_bb0365","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","article-title":"Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery","volume":"65","author":"Landen","year":"2005","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.canlet.2012.08.024","article-title":"Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells","volume":"334","author":"Landesman-Milo","year":"2013","journal-title":"Cancer Lett"},{"issue":"12","key":"10.1016\/j.biotechadv.2015.04.008_bb0375","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/mt.2012.190","article-title":"Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes","volume":"20","author":"Leconet","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0395","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jconrel.2014.04.012","article-title":"Bioreducible polymers for therapeutic gene delivery","volume":"190","author":"Lee","year":"2014","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0385","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virusres.2004.01.015","article-title":"Control of HIV-1 replication by RNA interference","volume":"102","author":"Lee","year":"2004","journal-title":"Virus Res"},{"issue":"28","key":"10.1016\/j.biotechadv.2015.04.008_bb0390","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1002\/anie.200800963","article-title":"Charge-conversion ternary polyplex with endosome disruption moiety: a technique for efficient and safe gene delivery","volume":"47","author":"Lee","year":"2008","journal-title":"Angew Chem Int Ed Engl"},{"issue":"4","key":"10.1016\/j.biotechadv.2015.04.008_bb0380","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nmat3253","article-title":"Self-assembled RNA interference microsponges for efficient siRNA delivery","volume":"11","author":"Lee","year":"2012","journal-title":"Nat Mater"},{"issue":"16","key":"10.1016\/j.biotechadv.2015.04.008_bb0400","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1038\/sj.emboj.7600345","article-title":"PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase","volume":"23","author":"Leenders","year":"2004","journal-title":"EMBO J"},{"issue":"12","key":"10.1016\/j.biotechadv.2015.04.008_bb0405","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/gt.2011.100","article-title":"Chemical modification and design of anti-miRNA oligonucleotides","volume":"18","author":"Lennox","year":"2011","journal-title":"Gene Ther"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0410","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejps.2013.10.011","article-title":"Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy","volume":"52","author":"Li","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"10.1016\/j.biotechadv.2015.04.008_bb0415","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1021\/bc500414e","article-title":"Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy","volume":"25","author":"Li","year":"2014","journal-title":"Bioconjug Chem"},{"issue":"10","key":"10.1016\/j.biotechadv.2015.04.008_bb0420","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1073\/pnas.1031523100","article-title":"Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells","volume":"100","author":"Liu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.biotechadv.2015.04.008_bb0430","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s13238-013-3092-z","article-title":"Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development","volume":"4","author":"Liu","year":"2013","journal-title":"Protein Cell"},{"issue":"18","key":"10.1016\/j.biotechadv.2015.04.008_bb0425","doi-asserted-by":"crossref","first-page":"11805","DOI":"10.1093\/nar\/gku831","article-title":"Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA","volume":"42","author":"Liu","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.biotechadv.2015.04.008_bb0435","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1021\/bc300486k","article-title":"Neutral polymeric micelles for RNA delivery","volume":"24","author":"Lundy","year":"2013","journal-title":"Bioconjug Chem"},{"issue":"5","key":"10.1016\/j.biotechadv.2015.04.008_bb0440","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/bc100070g","article-title":"Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects","volume":"21","author":"Maeda","year":"2010","journal-title":"Bioconjug Chem"},{"issue":"7","key":"10.1016\/j.biotechadv.2015.04.008_bb0445","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cas.12152","article-title":"The link between infection and cancer: tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect","volume":"104","author":"Maeda","year":"2013","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.biotechadv.2015.04.008_bb0450","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/138920209788185252","article-title":"MicroRNA: implications for Alzheimer disease and other human CNS disorders","volume":"10","author":"Maes","year":"2009","journal-title":"Curr Genomics"},{"issue":"10","key":"10.1016\/j.biotechadv.2015.04.008_bb0455","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1021\/bm300892v","article-title":"Glycine-terminated dendritic amphiphiles for nonviral gene delivery","volume":"13","author":"Malhotra","year":"2012","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0460","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jconrel.2011.12.021","article-title":"Administration, distribution, metabolism and elimination of polymer therapeutics","volume":"161","author":"Markovsky","year":"2012","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0465","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.yexmp.2014.08.002","article-title":"Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis","volume":"97","author":"Maroof","year":"2014","journal-title":"Exp Mol Pathol"},{"issue":"2\u20133","key":"10.1016\/j.biotechadv.2015.04.008_bb0470","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0014-5793(00)01894-9","article-title":"Observation of DNA\u2013polymer condensate formation in real time at a molecular level","volume":"480","author":"Martin","year":"2000","journal-title":"FEBS Lett"},{"issue":"12 Pt 1","key":"10.1016\/j.biotechadv.2015.04.008_bb0475","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res"},{"issue":"13\u201314","key":"10.1016\/j.biotechadv.2015.04.008_bb0480","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.drudis.2011.05.002","article-title":"PLK1 as an oncology target: current status and future potential","volume":"16","author":"McInnes","year":"2011","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.biotechadv.2015.04.008_bb0485","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1021\/mp900107v","article-title":"Nonviral siRNA delivery to the lung: investigation of PEG\u2013PEI polyplexes and their in vivo performance","volume":"6","author":"Merkel","year":"2009","journal-title":"Mol Pharm"},{"issue":"9","key":"10.1016\/j.biotechadv.2015.04.008_bb0490","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jemt.20839","article-title":"Structural and functional consequences of poly(ethylene glycol) inclusion on DNA condensation for gene delivery","volume":"73","author":"Millili","year":"2010","journal-title":"Microsc Res Tech"},{"issue":"12","key":"10.1016\/j.biotechadv.2015.04.008_bb0495","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.drudis.2014.09.019","article-title":"siRNA nanotherapeutics: a Trojan horse approach against HIV","volume":"19","author":"Mishra","year":"2014","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0500","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/mp200481g","article-title":"Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy","volume":"9","author":"Mo","year":"2012","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.biotechadv.2015.04.008_bb0505","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/bc900558z","article-title":"Hybrid PET\/CT for noninvasive pharmacokinetic evaluation of dynamic PolyConjugates, a synthetic siRNA delivery system","volume":"21","author":"Mudd","year":"2010","journal-title":"Bioconjug Chem"},{"issue":"4","key":"10.1016\/j.biotechadv.2015.04.008_bb0510","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrc2619","article-title":"MicroRNAs\u2014the micro steering wheel of tumour metastases","volume":"9","author":"Nicoloso","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0515","series-title":"The Nobel Prize in Physiology or Medicine 2006","author":"Nobelprize.org","year":"2014"},{"issue":"11","key":"10.1016\/j.biotechadv.2015.04.008_bb0520","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1021\/bm501148y","article-title":"Size-dependent knockdown potential of siRNA-loaded cationic nanohydrogel particles","volume":"15","author":"Nuhn","year":"2014","journal-title":"Biomacromolecules"},{"issue":"27","key":"10.1016\/j.biotechadv.2015.04.008_bb0525","doi-asserted-by":"crossref","first-page":"7887","DOI":"10.1016\/j.biomaterials.2014.05.041","article-title":"Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors","volume":"35","author":"Oe","year":"2014","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biotechadv.2015.04.008_bb0530","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1096\/fj.09-149641","article-title":"In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers","volume":"24","author":"Ofek","year":"2010","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.biotechadv.2015.04.008_bb0535","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1021\/bc015525a","article-title":"In vitro gene transfection using dendritic poly(l-lysine)","volume":"13","author":"Ohsaki","year":"2002","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0540","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1742-4690-1-44","article-title":"HIV-1 nef suppression by virally encoded microRNA","volume":"1","author":"Omoto","year":"2004","journal-title":"Retrovirology"},{"issue":"11","key":"10.1016\/j.biotechadv.2015.04.008_bb0545","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2174\/138955707782331678","article-title":"RNA interference as a tool for Alzheimer's disease therapy","volume":"7","author":"Orlacchio","year":"2007","journal-title":"Mini Rev Med Chem"},{"issue":"7","key":"10.1016\/j.biotechadv.2015.04.008_bb0550","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1775","article-title":"Design and development of polymers for gene delivery","volume":"4","author":"Pack","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.biotechadv.2015.04.008_bb0555","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/bc300600a","article-title":"Endosomolytic bioreducible poly(amido amine disulfide) polymer conjugates for the in vivo systemic delivery of siRNA therapeutics","volume":"24","author":"Parmar","year":"2013","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0560","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/bm8009973","article-title":"Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting","volume":"10","author":"Patil","year":"2009","journal-title":"Biomacromolecules"},{"issue":"71","key":"10.1016\/j.biotechadv.2015.04.008_bb0565","doi-asserted-by":"crossref","first-page":"8901","DOI":"10.1039\/c2cc34466a","article-title":"A low-molecular-weight supramolecular hydrogel of riboflavin bolaamphiphile for VEGF-siRNA delivery","volume":"48","author":"Patil","year":"2012","journal-title":"Chem Commun (Camb)"},{"issue":"3","key":"10.1016\/j.biotechadv.2015.04.008_bb9925","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry's grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat Rev Drug Discov."},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0570","doi-asserted-by":"crossref","first-page":"574136","DOI":"10.1155\/2013\/574136","article-title":"Chitosan combined with poly-l-arginine as efficient, safe, and serum-insensitive vehicle with RNase protection ability for siRNA delivery","volume":"2013","author":"Plianwong","year":"2013","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0575","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/mt.2011.210","article-title":"Delivery of siRNA to the mouse lung via a functionalized lipopolyamine","volume":"20","author":"Polach","year":"2012","journal-title":"Mol Ther"},{"issue":"6","key":"10.1016\/j.biotechadv.2015.04.008_bb0580","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1021\/mp700080m","article-title":"Single lipoplex study of cationic lipoid-DNA, self-assembled complexes","volume":"4","author":"Pozharski","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0585","first-page":"1001","article-title":"Polymeric nanoparticles for targeted treatment in oncology: current insights","volume":"10","author":"Prabhu","year":"2015","journal-title":"Int J Nanomedicine"},{"issue":"Suppl. 1","key":"10.1016\/j.biotechadv.2015.04.008_bb0590","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.jconrel.2011.08.068","article-title":"Preparation and characterization of guanidinated N-3-aminopropyl methacrylamide-N-2-hydroxypropyl methacrylamide copolymers as gene delivery carriers","volume":"152","author":"Qin","year":"2011","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.biotechadv.2015.04.008_bb0595","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.7150\/ijbs.7502","article-title":"The vascular endothelium and human diseases","volume":"9","author":"Rajendran","year":"2013","journal-title":"Int J Biol Sci"},{"issue":"12","key":"10.1016\/j.biotechadv.2015.04.008_bb0600","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann Oncol"},{"issue":"32","key":"10.1016\/j.biotechadv.2015.04.008_bb0605","doi-asserted-by":"crossref","first-page":"12982","DOI":"10.1073\/pnas.0703778104","article-title":"Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes","volume":"104","author":"Rozema","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0610","series-title":"DNA and RNA nanotechnologies in medicine. Diagnosis and treatment of diseases","first-page":"349","article-title":"Nanoscale-based delivery of RNAi for cancer therapy","author":"Scomparin","year":"2013"},{"issue":"9","key":"10.1016\/j.biotechadv.2015.04.008_bb0615","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/jemt.20856","article-title":"Dynamics of nucleic acid\/cationic polymer complexation and disassembly under biologically simulated conditions using in situ atomic force microscopy","volume":"73","author":"Shim","year":"2010","journal-title":"Microsc Res Tech"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0620","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejpb.2009.09.005","article-title":"Utilising atomic force microscopy for the characterisation of nanoscale drug delivery systems","volume":"74","author":"Sitterberg","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"issue":"41","key":"10.1016\/j.biotechadv.2015.04.008_bb0625","doi-asserted-by":"crossref","first-page":"15417","DOI":"10.1021\/ja404941p","article-title":"Poly(trehalose): sugar-coated nanocomplexes promote stabilization and effective polyplex-mediated siRNA delivery","volume":"135","author":"Sizovs","year":"2013","journal-title":"J Am Chem Soc"},{"issue":"31","key":"10.1016\/j.biotechadv.2015.04.008_bb0630","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1016\/j.biomaterials.2013.06.051","article-title":"Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction","volume":"34","author":"Somasuntharam","year":"2013","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biotechadv.2015.04.008_bb0635","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nm828","article-title":"RNA interference targeting Fas protects mice from fulminant hepatitis","volume":"9","author":"Song","year":"2003","journal-title":"Nat Med"},{"issue":"7014","key":"10.1016\/j.biotechadv.2015.04.008_bb0640","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs","volume":"432","author":"Soutschek","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0645","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5414\/CPP50076","article-title":"Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors","volume":"50","author":"Strumberg","year":"2012","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.biotechadv.2015.04.008_bb0650","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/2159-8290.CD-12-0429","article-title":"First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement","volume":"3","author":"Tabernero","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0655","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbiotec.2014.01.029","article-title":"Quick nuclear transportation of siRNA and in vivo hepatic ApoB gene silencing with galactose-bearing polymeric carrier","volume":"175","author":"Tachibana","year":"2014","journal-title":"J Biotechnol"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1745-7254.2007.00491.x","article-title":"Exploring in vitro roles of siRNA in cardiovascular disease","volume":"28","author":"Tang","year":"2007","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0665","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/BJ20110352","article-title":"Glucan particles for selective delivery of siRNA to phagocytic cells in mice","volume":"436","author":"Tesz","year":"2011","journal-title":"Biochem J"},{"issue":"250","key":"10.1016\/j.biotechadv.2015.04.008_bb0670","doi-asserted-by":"crossref","first-page":"250ra116","DOI":"10.1126\/scitranslmed.3009706","article-title":"Marburg virus infection in nonhuman primates: therapeutic treatment by lipid-encapsulated siRNA","volume":"6","author":"Thi","year":"2014","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0675","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1166\/jbn.2014.1715","article-title":"Interfering cancer with polymeric siRNA nanomedicines","volume":"10","author":"Tiram","year":"2014","journal-title":"J Biomed Nanotechnol"},{"issue":"4","key":"10.1016\/j.biotechadv.2015.04.008_bb0680","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00232-014-9637-0","article-title":"Transferrin receptor-mediated endocytosis: a useful target for cancer therapy","volume":"247","author":"Tortorella","year":"2014","journal-title":"J Membr Biol"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0685","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejpb.2012.08.014","article-title":"Comparison of four different particle sizing methods for siRNA polyplex characterization","volume":"84","author":"Troiber","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"issue":"50","key":"10.1016\/j.biotechadv.2015.04.008_bb0690","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/onc.2011.210","article-title":"EphA2 is a critical oncogene in melanoma","volume":"30","author":"Udayakumar","year":"2011","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.biotechadv.2015.04.008_bb0695","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0700","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6750-9-38","article-title":"Acetylation of PAMAM dendrimers for cellular delivery of siRNA","volume":"9","author":"Waite","year":"2009","journal-title":"BMC Biotechnol"},{"issue":"42","key":"10.1016\/j.biotechadv.2015.04.008_bb0705","doi-asserted-by":"crossref","first-page":"13735","DOI":"10.1021\/jp901835u","article-title":"DNA release dynamics from bioreducible poly(amido amine) polyplexes","volume":"113","author":"Wan","year":"2009","journal-title":"J Phys Chem B"},{"issue":"4","key":"10.1016\/j.biotechadv.2015.04.008_bb0710","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1208\/s12248-010-9210-4","article-title":"Delivery of siRNA therapeutics: barriers and carriers","volume":"12","author":"Wang","year":"2010","journal-title":"AAPS J"},{"issue":"1\u20132","key":"10.1016\/j.biotechadv.2015.04.008_bb0715","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijpharm.2010.08.026","article-title":"Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment","volume":"400","author":"Wang","year":"2010","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.biotechadv.2015.04.008_bb0720","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1039\/b900880b","article-title":"In vivo siRNA delivery with dendritic poly(l-lysine) for the treatment of hypercholesterolemia","volume":"5","author":"Watanabe","year":"2009","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0725","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-chembioeng-061010-114133","article-title":"Silencing or stimulation? siRNA delivery and the immune system","volume":"2","author":"Whitehead","year":"2011","journal-title":"Annu Rev Chem Biomol Eng"},{"issue":"6","key":"10.1016\/j.biotechadv.2015.04.008_bb0730","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1089\/nat.2012.0389","article-title":"Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in vivo","volume":"22","author":"Wong","year":"2012","journal-title":"Nucleic Acid Ther"},{"issue":"5","key":"10.1016\/j.biotechadv.2015.04.008_bb0735","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/mt.2013.31","article-title":"Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection","volume":"21","author":"Wooddell","year":"2013","journal-title":"Mol Ther"},{"issue":"10","key":"10.1016\/j.biotechadv.2015.04.008_bb0750","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1517\/14712598.4.10.1649","article-title":"Inhibition of hepatitis viral replication by siRNA","volume":"4","author":"Wu","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"10.1016\/j.biotechadv.2015.04.008_bb0745","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1021\/bi00403a008","article-title":"Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro","volume":"27","author":"Wu","year":"1988","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.biotechadv.2015.04.008_bb0755","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/1061186X.2012.699057","article-title":"Recent progress in copolymer-mediated siRNA delivery","volume":"20","author":"Wu","year":"2012","journal-title":"J Drug Target"},{"issue":"6","key":"10.1016\/j.biotechadv.2015.04.008_bb0740","doi-asserted-by":"crossref","first-page":"e66416","DOI":"10.1371\/journal.pone.0066416","article-title":"An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biotechadv.2015.04.008_bb0760","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2011.09.093","article-title":"Uptake mechanisms of non-viral gene delivery","volume":"158","author":"Xiang","year":"2012","journal-title":"J Control Release"},{"issue":"6","key":"10.1016\/j.biotechadv.2015.04.008_bb0765","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1021\/nn2013707","article-title":"Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin","volume":"5","author":"Xiong","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0770","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jconrel.2014.06.038","article-title":"Insight into nanoparticle cellular uptake and intracellular targeting","volume":"190","author":"Yameen","year":"2014","journal-title":"J Control Release"},{"issue":"28","key":"10.1016\/j.biotechadv.2015.04.008_bb0775","doi-asserted-by":"crossref","first-page":"9006","DOI":"10.1021\/ja800086u","article-title":"Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging","volume":"130","author":"Yezhelyev","year":"2008","journal-title":"J Am Chem Soc"},{"issue":"11","key":"10.1016\/j.biotechadv.2015.04.008_bb0780","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1021\/bc400226b","article-title":"Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice","volume":"24","author":"Yhee","year":"2013","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1016\/j.biotechadv.2015.04.008_bb0785","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/bm901249n","article-title":"Rational design of targeted cancer therapeutics through the multiconjugation of folate and cleavable siRNA to RAFT-synthesized (HPMA-s-APMA) copolymers","volume":"11","author":"York","year":"2010","journal-title":"Biomacromolecules"},{"issue":"34","key":"10.1016\/j.biotechadv.2015.04.008_bb0795","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1002\/anie.201203920","article-title":"An amphiphilic dendrimer for effective delivery of small interfering RNA and gene silencing in vitro and in vivo","volume":"51","author":"Yu","year":"2012","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"10.1016\/j.biotechadv.2015.04.008_bb0790","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1182\/blood-2012-01-407742","article-title":"Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia","volume":"121","author":"Yu","year":"2013","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.biotechadv.2015.04.008_bb0800","doi-asserted-by":"crossref","first-page":"12221","DOI":"10.1128\/JVI.01557-08","article-title":"RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response","volume":"82","author":"Zhang","year":"2008","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.biotechadv.2015.04.008_bb0805","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/mt.2011.207","article-title":"Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice","volume":"19","author":"Zhou","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.biotechadv.2015.04.008_bb0810","first-page":"1940","article-title":"AFM study of the nanostructure of quenched isotactic polypropylene","volume":"3","author":"Zia","year":"2010"},{"issue":"51","key":"10.1016\/j.biotechadv.2015.04.008_bb0815","doi-asserted-by":"crossref","first-page":"20723","DOI":"10.1073\/pnas.1314307110","article-title":"Mutant KRAS is a druggable target for pancreatic cancer","volume":"110","author":"Zorde Khvalevsky","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.biotechadv.2015.04.008_bb0820","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1073\/pnas.1200718109","article-title":"Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane","volume":"109","author":"Zuckerman","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"10.1016\/j.biotechadv.2015.04.008_bb0825","doi-asserted-by":"crossref","first-page":"11449","DOI":"10.1073\/pnas.1411393111","article-title":"Correlating animal and human phase Ia\/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA","volume":"111","author":"Zuckerman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975015000737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975015000737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:41:37Z","timestamp":1589503297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975015000737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":167,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0734975015000737"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2015.04.008","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Achieving successful delivery of oligonucleotides \u2014 From physico-chemical characterization to in vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2015.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}